| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.110 | 14.377 | 18.215 | 30.205 | 37.092 | 43.128 | 73.600 | 53.452 | 50.574 | 71.196 |
| Total Income - EUR | 3.110 | 14.377 | 18.215 | 35.852 | 43.090 | 49.735 | 74.323 | 58.014 | 50.574 | 71.196 |
| Total Expenses - EUR | 5.952 | 8.047 | 12.350 | 25.195 | 35.220 | 42.976 | 72.654 | 57.229 | 45.124 | 74.528 |
| Gross Profit/Loss - EUR | -2.843 | 6.330 | 5.865 | 10.657 | 7.870 | 6.760 | 1.669 | 786 | 5.450 | -3.332 |
| Net Profit/Loss - EUR | -2.936 | 6.042 | 5.683 | 10.355 | 7.498 | 6.323 | 911 | 225 | 4.896 | -4.377 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Daxmedvet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 188 | 186 | 183 | 19.948 | 13.313 | 7.240 | 25.056 | 25.843 | 19.747 | 38.351 |
| Current Assets | 2.468 | 6.602 | 10.971 | 16.519 | 21.986 | 27.067 | 33.982 | 37.280 | 61.330 | 52.529 |
| Inventories | 2.409 | 5.770 | 7.349 | 14.480 | 15.991 | 18.633 | 17.333 | 32.273 | 58.472 | 48.779 |
| Receivables | 0 | 668 | 1.026 | 1.007 | 355 | 349 | 408 | 1.287 | 1.142 | 3.326 |
| Cash | 59 | 164 | 2.596 | 1.032 | 5.639 | 8.086 | 16.242 | 3.720 | 1.717 | 424 |
| Shareholders Funds | -3.611 | 2.468 | 8.109 | 18.315 | 25.459 | 31.300 | 31.517 | 31.840 | 31.836 | 27.168 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.268 | 4.321 | 3.045 | 5.766 | 3.627 | 2.733 | 27.522 | 31.283 | 49.241 | 63.711 |
| Income in Advance | 0 | 0 | 0 | 12.385 | 6.213 | 274 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Daxmedvet Srl